Brasada Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Brasada Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,984	Closed	-$4.39M	–	173
2026 Q1	$4.39M	Sell	8,984 -469	-5%	-$255K	0.8%	52
2025 Q4	$5.59M	Buy	9,453 +1,627	+21%	+$920K	0.94%	36
2025 Q3	$4.11M	Sell	7,826 -7,656	-49%	-$3.56M	0.69%	51
2025 Q2	$6.65M	Buy	15,482 +6,429	+71%	+$2.69M	1.13%	28
2025 Q1	$3.8M	Buy	+9,053	New	+$4.9M	0.76%	42
2024 Q4	–	Sell	-1,500	Closed	-$928K	–	151
2024 Q3	$928K	Buy	+1,500	New	+$888K	0.16%	92
2019 Q1	–	Sell	-15	Closed	-$3K	–	256
2018 Q4	$3K	Hold	15	–	–	﹤0.01%	270
2018 Q3	$4K	Buy	+15	New	+$3.45K	﹤0.01%	350

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Brasada Capital Management's TMO Position: Q2 2026 in Review

Brasada Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 8,984 shares — an estimated $4.39M sold.

Brasada Capital Management first reported a position in TMO in Q3 2018 and held it in 8 quarters. The position peaked at $6.65M in Q2 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Brasada Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Brasada Capital Management sold 8,984 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.39M.
Brasada Capital Management first reported a position in Thermo Fisher Scientific in Q3 2018 and held it in 8 quarters.
Brasada Capital Management's Thermo Fisher Scientific position peaked at $6.65M in Q2 2025.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Brasada Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.